A decade ago, the United Nations declared June 19 to be World Sickle Cell Awareness Day—and for good reason. This genetic condition warps round red blood cells into crescent-shaped ones that disrupt blood flow, damage organs, and cause frequent bouts of pain. Millions...
Study sponsored by Myotonic Dystrophy Clinical Research Network will advance understanding of disease progression and enable development of clinical outcome assessments Patients with DM1 aged 18-70 encouraged to enroll at study sites in U.S. and Europe Dyne...
The Standard vs ultrasound-assisted catheter thrombolysis for submassive pulmonary embolism(SUNSET sPE) trial, is an ongoing randomised, head-to-head, single-blinded clinical trial comparing ultrasound-assisted thrombolysis to standard catheter-directed thrombolysis....
– Primary endpoint achieved with 45% and 42% ORR in AITL and CXCL12+ AITL/PTCL-NOS expansion cohorts – – PTCL patients with tumors characterized by high CXCL12/CXCR4 expression ratio experienced an ORR of 47% and a clinical benefit rate of 82% – – 50% CR rate and 75%...
BioNTech SE, a clinical-stage biotechnology company focused on patient-specific immunotherapies for the treatment of cancer and other serious diseases, announced today that the first-in-human Phase I/IIa study with DuoBody-PD-L1x4-1BB has been initiated....
Email
Text